表紙
市場調查報告書
商品編碼
974393

COVID-19(新型冠狀病毒感染):流行病學分析和預測(2020年11月)

Coronavirus Disease 2019 (COVID-19) - Epidemiology Analysis and Forecast - November 2020

出版日期: | 出版商: GlobalData | 英文 38 Pages | 訂單完成後即時交付

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

該報告調查了COVID-19(新型冠狀病毒感染),並提供了一些信息,例如主要市場的預測和分析以及截至2020年11月的COVID-19的流行病學狀況。

目錄

目錄

第1章當前的流行病學狀況

  • 當前流行病學狀況
  • 10個主要感染國家的新病例趨勢

第2章主要市場預測

  • 對某些國家感染高峰和減少的預測
  • 預測100例確診病例後每天按國家分列的新確診病例數

第3章繼續發生

  • 拉丁美洲:雖然起步較晚,但趨勢令人擔憂,尚未達到頂峰。
  • 印度:COVID-19由於激增的風險,前景仍然不確定。
  • 秘魯:很少有嚴格的鎖定政策來遏制COVID-19的傳播。

第4章需要改進的地方

  • 紐西蘭:在100天內宣佈從COVID-19釋放的聲明。
  • 美國:COVID-19測試的陽性率正在穩步下降。
  • 印度:儘管每天確診的COVID-19病例數量正在迅速增加,但平均致死率卻相對較低。

第5章特殊小組

  • 少數群體:在英國和美國,死於COVID-19的可能性高2-3倍
  • CKD患者:由於大流行期間獲得初級保健的機會減少,許多人可能未得到診斷。
  • 霍奇金淋巴瘤患者:COVID-19增加死亡風險。
  • AML:由於病毒感染,潛在的風險增加。

第6章數據限制

第7章附錄

目錄
Product Code: GDHCHT213

The report covers current epidemiology situation, forecast, and analysis of COVID-19 in November 2020, including forecast for key markets.The report will be updated on a regular basis.

The report provide forecast for peak-week and return-to-normal week that will help the reader plan in this uncertain time, and highlights important populations and regions most affected by the outbreak.

Current Epidemiology Situation and Forecast

  • To date, the greatest numbers of cases and deaths have occurred in the US, India, and Brazil
  • The global case fatality rate (%) has continued to decline
  • Increasing uncertainty of infection rates renders forecasting difficult in the worst-hit countries

Region Focus

  • High positive test Rates in Poland suggest this is not the time to ease social distancing measures
  • Japan's initial COVID-19 response was not enough
  • Not enough evidence to suggest a major role of seasonality in surge of COVID-19 cases in Europe. 
  • Resurgence of COVID-19 cases in France is real as testing positivity rate continues to rise
  • Fears of second wave emerge in New York City

Special Populations:

  • Pregnant women with COVID-19 at greater risk for ICU admission but not mortality
  • COVID-19 severe complications and mortality risk is minute in school age children.

Impact on Diseases

  • COVID-19 pandemic could result in increased pulmonary fibrosis patients
  • Pulmonary arterial hypertension more likely to increase COVID-19 severity
  • Ulcerative colitis patients are at increased risk of COVID-19 infection

Scope

  • The epidemiology report covers the following areas: current epidemiology situation and forecast, outbreak analysis for key regions, impact of disease on special populations, impact of COVID-19 on other diseases, and data limitations.

Reasons to Buy

  • Obtain in-depth understanding of epidemiology data for COVID-19 and analysis of up-to-date new research and insights.

Table of Contents

Table of Contents

1 Current Epidemiology Situation

  • 1.1 Current Epidemiology Situation
  • 1.2 New Cases Trend in Top 10 Infected Countries

2 Forecast for Key Markets

  • 2.1 Infection Peak and Decline Forecasts for Select Countries
  • 2.2 Projections of Daily New Confirmed Cases for Select Countries, Since 100th Confirmed Case

3 Outbreak Continues

  • 3.1 Latin America Had a Slow Start but Shows Concerning Trends, and Has Not Yet Reached Peak Cases
  • 3.2 Risk of COVID-19 Surges in India as Outlook for the Future Remains Uncertain
  • 3.3 Strict Lockdown Policies in Peru Have Done Little to Curb the Spread of COVID-19

4 Areas of Improvement

  • 4.1 New Zealand Was Declared Free of COVID-19 After Less than 100 Days
  • 4.2 Positive COVID-19 Test Rates Are Steadily Declining in the US
  • 4.3 Despite the Recent Surge in the Daily Confirmed Cases of COVID-19 in India, the Average Case Fatality Rate is Relatively Low

5. Special Populations

  • 5.1 Minority Ethnic Groups Are Two to Three Times More Likely to Die of COVID-19 in the UK and US
  • 5.2 More CKD Patients Are Likely to Go Undiagnosed Due to Reduced Primary Care Access During the Pandemic
  • 5.3 COVID-19 Increases the Risk of Mortality in Patients with Hodgkin Lymphoma
  • 5.4 Viral Infections May Increase AML Risk

6 Data Limitations

  • 6.1 There Are Drawbacks to the Available Data

7 Appendix

  • 7.1 Methodology
  • 7.2 Abbreviations
  • 7.3 Related Reports
  • 7.4 Sources
  • 7.5 About the Authors
  • 7.6 About GlobalData
  • 7.7 Contact Us

List of Tables

List of Tables

  • Table 1. Current Epidemiology Situation
  • Table 2. Top 10 Infected Countries
  • Table 3. Estimated Peak Weeks and Decline to Zero New Cases Weeks for Top Infected Countries (Excluding China)​

List of Figures

List of Figures

  • Figure 1. Projections of Daily New Confirmed Cases for Select Countries, Since 100th Confirmed Case​
  • Figure 2. Poland, New Daily Cases (N), and Positive Test Rate (%), March - November 2020
  • Figure 3. Daily Confirmed Cases of COVID-19 in Japan, Men and Women, All Ages, March 26-November 9, 2020
  • Figure 4. COVID-19 Daily New Cases in the 5EU, March 1-November 12
  • Figure 5. New Daily Cases of COVID-19 and Testing Positivity Rate, France, May 19 - November 11
  • Figure 6. Daily Confirmed Cases of COVID-19 in New York City, Men and Women, All Ages
  • Figure 7. Age Distribution of Confirmed Cases of COVID-19 in Pregnant and Nonpregnant Women in the US, Ages 15-44 Years, %, 2020
  • Figure 8. UK, COVID-19 Hospitalization Number and Mortality Rate, March 1-July 3
  • Figure 9. Proportion of ARDS Cases Developing Fibrosis (%)
  • Figure 10. Cumulative Incidence of COVID-10 in General Population and in PAH/CTEPH Patients
  • Figure 11. 8MM, Diagnosed Incident Cases of Ulcerative Colitis 2019
  • Figure 12. Total prevalence of Major Depressive Disorder in the UK in 2019 versus 2020